Tools & Calculators
Sector: Pharmaceuticals & Biotechnology
|Large Cap
Wockhardt Ltd.
₹1,370
Invest in WOCKPHARMA with up to 2.22x margin.
Trade with MTF₹1353.20
₹1390.50
₹1110.05
₹1868.80
Markets Today
Historical Performance
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 430 | 380 | 413 | 355 | 325 |
| Operating Expense | 317 | 267 | 282 | 249 | 263 |
| Operating Profit | 113 | 113 | 131 | 106 | 62 |
| Depreciation | 52 | 45 | 46 | 40 | 42 |
| Interest | 50 | 44 | 41 | 40 | 48 |
| Tax | 0 | 0 | 0 | 0 | 0 |
| Net Profit | 28 | 54 | 69 | 40 | -22 |
₹1370.00
↗ Bullish Moving Average
0
↘ Bearish Moving Average
16
| Held By | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|
| Promoter | 52 | 49.1 | 49.1 | 49.1 | 49.1 | 49.1 |
| FII | 6.7 | 6.5 | 6.8 | 7.3 | 7.1 | 7 |
| DII | 5.1 | 9.9 | 10.6 | 11 | 11 | 10.6 |
| Public | 36.2 | 34.5 | 33.5 | 32.6 | 32.8 | 33.4 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 69.14 K | 1.94 L | 35.65% |
| Week | 1.49 L | 3.43 L | 43.44% |
| 1 Month | 1.79 L | 5.02 L | 35.54% |
| 6 Month | 2.33 L | 9.84 L | 23.70% |
Benjamin Graham Value Screen
Consistent high performing stocks over Five Years
Companies with high TTM EPS Growth
Expensive Performers (DVM)
Annual Profit Growth higher than Sector Profit Growth
High Momentum Scores (Technical Scores greater than 50)
Good quarterly growth in the recent results
Relative Outperformance versus Industry over 1 Week
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Increasing Revenue every quarter for the past 2 quarters
Annual Net Profits improving for last 2 years
Companies with decreasing Promoter pledge
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 17 Nov, 2016 | 10 | INTERIM | 19 Nov, 2016 | Equity Share |
| 13 Nov, 2014 | 20 | INTERIM | 15 Nov, 2014 | Equity Share |
| 17 Feb, 2014 | 5 | INTERIM | 19 Feb, 2014 | Equity Share |
| 07 Nov, 2013 | 5 | INTERIM | 08 Nov, 2013 | Equity Share |
| 22 Aug, 2013 | 5 | FINAL | Equity Share | |
| 17 Apr, 2008 | 2.5 | FINAL | Equity Share | |
| 26 Oct, 2007 | 8.75 | INTERIM | 29 Oct, 2007 | Equity Share |
| 22 Mar, 2007 | 5 | FINAL | 23 Mar, 2007 | Equity Share |
| 21 Jun, 2006 | 5 | FINAL | Equity Share | |
| 12 Apr, 2005 | 5 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹696.90 | ₹1,431.80 | ₹2,045 | ₹162 | ₹1,803 | ₹1,014.60 |
| % Change | 2.20% | -0.42% | 1.02% | 0.92% | -1.03% | -0.43% |
| Revenue TTM (₹ Cr) | ₹1,996.59 | ₹8,850.08 | ₹13,914.08 | ₹8,871.37 | ₹6,112.77 | ₹6,721.63 |
| Net Profit TTM (₹ Cr) | ₹484.66 | ₹869.92 | ₹1,779.35 | ₹-163.61 | ₹847.18 | ₹843.32 |
| PE TTM | 80.70 | 31.30 | 47.50 | -131.70 | 35.10 | 65.10 |
| 1 Year Return | 22.17 | 44.17 | -12.08 | -22.44 | 18.09 | 95.04 |
| ROCE | 26.88 | 20.80 | 13.27 | 6.40 | 11.43 | 11.82 |
Alkem Laboratories Ltd.
₹ 5487.00
+1.76%
Biocon Ltd.
₹ 388.00
+1.05%
Divi's Laboratories Ltd.
₹ 6258.50
-0.52%
Ajanta Pharma Ltd.
₹ 2975.00
+1.21%
Zydus Lifesciences Ltd.
₹ 905.30
-
Glenmark Pharmaceuticals Ltd.
₹ 2033.00
-0.50%
Aurobindo Pharma Ltd.
₹ 1148.70
-0.87%
Sun Pharmaceutical Industries Ltd.
₹ 1732.00
+0.44%
Ipca Laboratories Ltd.
₹ 1469.70
+1.37%
J B Chemicals & Pharmaceuticals Ltd.
₹ 2051.00
+2.53%
AstraZeneca Pharma India Ltd.
₹ 8807.00
-0.93%
GlaxoSmithKline Pharmaceuticals Ltd.
₹ 2635.30
+1.48%
Pfizer Ltd.
₹ 5066.60
+2.74%
Abbott India Ltd.
₹ 26425.00
+0.49%
Torrent Pharmaceuticals Ltd.
₹ 4318.50
+1.81%
Lupin Ltd.
₹ 2241.00
+0.97%
Dr. Reddy's Laboratories Ltd.
₹ 1305.10
+1.93%
Cipla Ltd.
₹ 1327.00
-1.05%
By signing up I certify terms, conditions & privacy policy